Optimi Health Corp. (NASDAQ:OPTH)
| Market Cap | $12.65M-71.7% |
| Revenue (ttm) | $134.17K-75.5% |
| Net Income | -$6.19M-51.4% |
| EPS | -$1.78-134.2% |
| Shares Out | 5.73M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,929 |
| Open | $2.17 |
| Previous Close | $2.18 |
| Day's Range | $2.14 - $2.36 |
| 52-Week Range | $1.90 - $8.84 |
| Beta | 1.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
About OPTH
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Next catalysts
- Nov 13, 2026Earnings report
$OPTH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in OPTH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OPTH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OPTH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OPTH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OPTH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OPTH
| PSILAdvisorShares Psychedelics ETF | $595.22K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from OPTH’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.
Frequently Asked Questions
Upcoming unlocks
ETFs that hold this stock
| PSIL | AdvisorShares Psychedelics ETF | 1.39% |
Weight is the stock’s share of each fund’s holdings.